Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Other Current Assets
$2,268 Mil (As of Jun. 2014)

Teva Pharmaceutical Industries Ltd's other current assets for the quarter that ended in Jun. 2014 was $2,268 Mil.

Teva Pharmaceutical Industries Ltd's quarterly other current assets increased from Dec. 2013 ($2,291 Mil) to Mar. 2014 ($2,296 Mil) but then declined from Mar. 2014 ($2,296 Mil) to Jun. 2014 ($2,268 Mil).

Teva Pharmaceutical Industries Ltd's annual other current assets increased from Dec. 2011 ($2,132 Mil) to Dec. 2012 ($2,402 Mil) but then declined from Dec. 2012 ($2,402 Mil) to Dec. 2013 ($2,291 Mil).


Definition

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, “other current assets” never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


• Cash
• Trade Receivables
• Inventory

The assets grouped under “other current assets” are most commonly:


• Prepaid Expenses
• Tax Assets
• Non-Trade Receivables
• Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of “Prepaid Expenses” - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company’s financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line “Other Current Assets”.

At most companies, “other current assets” are a small and unimportant part of the total balance sheet.


Related Terms

Total Current Assets


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Other Current Assets 3994107959981,4701,4421,6162,1322,4022,291

Teva Pharmaceutical Industries Ltd Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Other Current Assets 2,5172,3142,3082,4022,2212,2152,3232,2912,2962,268
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK